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ABSTRACT – Context - Zinc deficiency in children and adolescents impairs their growing, development and immune system. Objectives - To 
verify the existence of plasma and leukocyte zinc deficiency in adolescents with autoimmune hepatitis. Methods - The study comprised 
23 patients with autoimmune hepatitis, aged 10-18 years, assisted at the Ambulatory Service of Pediatric Hepatology of the University 
of Campinas Teaching Hospital, Campinas, SP, Brazil, and adolescents with ages compatible with the patients’ ages comprised the 
control group. Sample of blood in both groups was collected for the analyses of plasma zinc and leukocyte zinc by atomic absorption 
spectrophotometry, beyond the nutritional status was evaluated in each adolescent. The following statistical tests were used: Mann-
Whitney, Spearman’s correlation and interclass concordance analysis. Results - The significance level adopted was 5%. The average 
zinc level in plasma in patients was 71.91 ± 11.79 µg/dL and, in the control group, it was 80.74 ± 10.92 µg/dL, showing a significant 
difference (P = 0.04). The leukocyte zinc level in patients was 222.33 ± 166.13 pmol/106 cells and, in the control group, it was 226.64 
± 217.81 pmol/106 cells; there was no statistical significance between them (P = 0.45). Conclusion - The evaluation of the nutritional 
status showed that eutrophy is prevalent in patients, and they presented a higher body fat value than the control group, with a significant 
difference. More research is needed with adolescents with autoimmune hepatitis regarding levels of essential micronutrients, such as 
zinc, because a good nutritional status can improve the prognostic of liver disease.
HEADINGS - Hepatitis autoimmune. Zinc deficiency. Nutritional status. Adolescent. Child.
INTRODUCTION
Autoimmune hepatitis (AIH) is a rare disease, with 
an annual incidence rate of 0.85 cases per 100,000 
inhabitants. Affecting children and adults, its prevalence 
is greater in age groups from 10-20 and 45-70 years 
old. Seventy-five percent of the cases are women(3, 
22). It is a chronic inflammatory disease of unknown 
etiology, presenting itself  in more than half  of the 
cases with signs and symptoms resembling those of 
acute viral hepatitis (jaundice, choluria, anorexia). 
In other patients, its presentation is very variable; 
sometimes it appears in an insidious way, other times 
by signs of portal hypertension, and more rarely by 
acute liver insufficiency(7).
AIH is classified into three types, according to the 
presence of non-organ-specific auto antibodies. It is called 
type 1 AIH when anti-smooth muscle antibodies, mainly 
of the antiactine and/or antinuclear types, are found. 
In type 2 AIH, anti-liver-kidney microsomal antibody 
is found(10, 11). Type 3 AIH is rare, prevalent in women 
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between 20 and 40 years old, featuring the presence 
of autoantibody to soluble liver-pancreas(21).
The treatment for this disease is based on 
immunosuppresion by using prednisone and azathioprine 
at the respective doses of 1-2 mg/kg/day (maximum 
60 mg/day) and 1-2 mg/kg/day (maximum 75 mg/
day). The ministration scheme consists of high doses 
in the beginning of  the treatment, with reduction 
every 2 months or according to the evolution of the 
laboratory exams(18).
Maintenance of  the nutritional state of  AIH 
patients is important for a better prognosis, especially 
in patients who will undergo a liver transplant. In the 
pediatric age group, patients are going through a phase 
of weight gain, growth and bone formation. However, 
there are few researches about these parameters in such 
patients without a study about the specific nutritional 
deficiencies, such as oligoelements like zinc (Zn)(1, 4).
Zn is an essential mineral that is active in several 
body functions, once it acts as a cofactor for more 
than 300 enzymes and proteins. It is important in the 
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activities of the immune system by preventing the formation 
of  free radicals, in stature growth, sexual and cognitive 
development and DNA synthesis(5, 23). This mineral is found 
in great quantities in products of animal origin and seafood, 
mainly in red meat, shellfish, oyster, liver, viscera, and eggs. 
Daily Zn consumption for healthy individuals varies according 
to age, for children and adolescents between 1 and 18 years 
old, it varies from 3 to 11 mg/day(12).
Signs and clinical symptoms of Zn deficiency include growth 
delay, hypogonadism, decreased appetite and hypogeusia, 
decreased cognitive functions, enteropathic acrodermatitis, 
alopecia, diarrhea, skin rash and immunodeficiency(23). The 
specialized literature reports difficulty in establishing a trusted 
indicator to determine Zn deficiency, despite the difficulty 
of its method of analysis, some studies have affirmed that 
leukocyte Zn is the most trustworthy biomarker(2, 8).
Studies that evaluate Zn level in children and adolescent 
carriers of chronic liver diseases are scarce. There are no 
conclusive studies for certain diseases, such as autoimmune 
hepatitis; however, according to the recent literature, it seems 
that children and adolescents with chronic liver diseases present 
a tendency for Zn deficiency, since 42% of this population 
was diagnosed with lack of this chemical element(16). That is 
why the aim of the present study was to verify the existence 
of plasma or leukocyte Zn deficiency in AIH adolescents.
METHODS
This study comprised male and female AIH patients 
aged 10-18 years old attending the Pediatric Hepatology 
Ambulatory Service of the University of Campinas Teaching 
Hospital (HC-UNICAMP), from January 2007 to March 
2008. The control group consisted of apparently healthy 
individuals paired with the patient group according to age. 
The participants’ parents or legal guardians signed the free 
informed consent form.
After at least 8 hours of fasting, adolescents had their 
blood collected and, on the same day, anthropometric data 
were obtained.
Plasma Zn was determined by the Biochemistry Laboratory 
of the UNICAMP Teaching Hospital, and the leukocyte 
Zn analysis was carried out by the researcher. The method 
of atomic absorption spectrophotometry was used in both 
procedures, and they followed standard literature methods(2, 9). 
The normality value of plasma Zn used was the one adopted 
by the UNICAMP Teaching Hospital, varying between 80 
and 120 µg/dL. Since leukocyte Zn does not yet present a 
normality value stipulated by epidemiological studies, the 
result was compared with the control group.
The measurement technique based on the method 
standardized by Lohman et al.(13) was used for collecting 
weight, height, tricipital cutaneous fold and subscapular 
cutaneous fold. The percentage of body fat was obtained by 
the equation of Slaughter et al.(20). The body mass index (BMI), 
height-for-age z-score (H/A), weight-for-height z-score (W/H) 
and weight-for-age z-score (W/A) was classified according to 
international reference data(14, 15, 24).
Statistical data were processed using SPSS (Statistical 
Package for Social Science) version 7.5 for Windows. Mann-
Whitney’s U test was used to compare data of the patient group 
with those of the control group. Spearman’s rank correlation 
was also used to verify the existence of correlation between 
the variables. The data considered significant for significance 
analysis were those with P<0.05.
RESULTS
This study comprised 23 AIH patients, 17 females and 
6 males, with average age of  12.93 ± 1.98 years. In the 
patient group, 17 patients were diagnosed with type 1 AIH, 
2 patients with type 2, and 4 patients were AIH without 
classification.
The results of plasma and leukocyte Zn analysis are shown 
in Table 1. The average Zn level in plasma (µg/dL) in the patient 
group was 71.91 ± 11.79 and, in the control group, 80.74 ± 
10.92, demonstrating a statistically significant difference (P 
= 0.04). The average Zn levels in leukocytes (pmol/106 cells) 
in the patient group was 222.33 ± 166.13 and, in the control 
group, 226.64 ± 217.81, demonstrating a non-significant 
difference (P = 0.45). There was no correlation between 
plasma Zn and leukocyte Zn levels (P = 0.29).
Variable
Average and  
standard deviation P
Patient group Control group
(n = 23) (n = 23)
Plasma Zn (µg/dL) 71.91 ± 11.79 80.74 ± 10.92 0.04*





TABLE 1. Average, standard deviation and significance analysis (P) of 
plasma Zn and leukocyte Zn of the patient group with AIH and the 
control group
* P<0.05: statistically significant difference between the patient group and the control group
Regarding normality values adopted, 65.2% (n = 15) of 
the adolescents with AIH presented plasma Zn deficiency.
Data of four patients who presented edema were not 
considered for evaluation of anthropometric indexes so as to 
prevent the results from being overestimated. For this reason, 
the patient group had 19 patients, and the control group still 
had 23 individuals for those indexes.
The BMI had an average 21.93 ± 5.30 kg/m2 in the 
patient group and 18.65 ± 2.53 kg/m2 in the control group, 
demonstrating statistical significance, with P = 0.02. Classifying 
the patients’ BMI according to age, it was verified that 68.4% 
(n = 13) of them had eutrophy, and 31.6% (n = 6) were obese. 
No patient had malnutrition in relation to the BMI. Body 
fat percentage was 25.77% ± 9.47% for the patient group 
and 18.99% ± 6.40% for the control group, demonstrating 
statistical significance (P = 0.01).
Most patients were in a state of eutrophy for W/H (73.7%), 
W/A (89.4%) and H/A (87.0%). Only 5.3% of the patients 
were classified as obese according to the W/A index and, for 
the W/H index, the frequency of obesity was 26.3%. Acute 
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Pereira TC, Saron MLG, Carvalho WA, Vilela MM, Hoehr NF, Hessel G.  Investigação do nível de zinco sanguíneo e estado nutricional em adolescentes 
com hepatite autoimune.  Arq Gastroenterol. 2011;48(1):62-5.
RESUMO - Contexto - A deficiência de zinco em crianças ou adolescentes acarreta danos ao crescimento, desenvolvimento e ao sistema imune dos 
indivíduos. Objetivo - Verificar a existência de deficiência de zinco plasmático e/ou leucocitário em adolescentes com hepatite autoimune. Métodos - 
Participaram do estudo 23 pacientes com hepatite autoimune entre 10 e 18 anos, atendidos no Ambulatório de Hepatologia Pediátrica do Hospital 
de Clínicas da UNICAMP – Campinas, SP e 23 adolescentes com idade pareada com os pacientes formaram o grupo controle. Foi coletada amostra 
de sangue de todos os pacientes e grupo controle para as análises de zinco plasmático e zinco leucocitário por meio da espectrofotometria de 
absorção atômica, além de ter sido verificado o estado nutricional de cada adolescente. Os testes estatísticos empregados foram o de Mann-Whitney, 
correlação de Spearman e análise de concordância interclasses. Resultados - O nível de significância adotado foi de 5%. A média de zinco plasmático 
nos pacientes foi de 71.91 ± 11.79 µg/dL e no grupo controle foi de 80.74 ± 10.92 µg/dL, essa diferença foi significante (P = 0.04). O nível de zinco 
leucocitário nos pacientes foi igual a 222.33 ± 166.13 pmol/106 células e no grupo controle foi de 226.64 ± 217.81 pmol/106 células, não ocorrendo 
diferença estatisticamente significante entre estes (P = 0.45). Conclusão - A avaliação do estado nutricional mostrou que a eutrofia é prevalente 
nos pacientes e estes possuem maior valor de gordura corporal que o grupo controle com diferença significativa. São necessárias mais pesquisas 
com adolescentes com hepatite autoimune em relação aos níveis de micronutrientes essenciais, como o zinco, pois um bom estado nutricional pode 
melhorar o prognóstico da doença hepática.
DESCRITORES - Hepatite autoimune. Deficiência de zinco. Estado nutricional. Adolescente. Crianças.
malnutrition was not present according to the W/H index; 
however, according to the W/A index, one case was diagnosed 
and, for the H/A, two cases of chronic malnutrition with 
stature growth deficit were diagnosed. 
There was no correlation between any indicators of 
nutritional state and plasma or leukocyte Zn levels.
DISCUSSION
The importance of studies about Zn status in humans, mainly 
in children and adolescents, is emphasized in the literature due 
to the countless body activities in which Zn takes part, especially 
promoting enzymatic reactions related to the growth and 
development of children and adolescents. Researches currently 
underway have highlighted how difficult it is to find a safe indicator 
to determine Zn deficiency in humans(8, 23). The difficulty in 
finding trusted Zn deficiency indicators was equally observed 
in the present study. While it was noticed plasma Zn deficiency, 
leukocyte Zn deficiency was not noticed in AIH adolescents 
when the average of these indicators was checked against that 
of the control group. Furthermore, the two Zn level indicators 
had no correlation between themselves. The same absence of 
correlation was observed by Goode et al.(6), who studied leukocyte 
and plasma Zn levels in 13 adults with alcoholic cirrhosis and 
17 with nonalcoholic cirrhosis, and verified that the plasma Zn 
level was low in both groups, whereas leukocyte Zn was normal 
when compared with the control group.
Schneider et al.(19) evaluated plasma Zn concentration in 31 
children and adolescents with cirrhosis (9 of them with AIH), 
and found 42% of the patients with plasma Zn deficiency, 
occurring a positive correlation between the gravity of the 
disease and the presence of cholestasis. It was observed that 
the frequency of plasma Zn in the present patients (62.2%) 
was greater than in the cited study. This can suggest that AIH 
patients are more prone to Zn deficiency than patients with 
other diagnoses of chronic liver diseases.
Ferreira et al.(4) observed that children and adolescents 
with AIH presented a significant reduction in the H/A z-score. 
However, Porta(17) did not find weight or height differences in 
children with AIH and Bellomo-Brandão et al.(1) did not observe 
low stature in patients with type 1 and type 2 AIH. The present 
study agrees with the two last cited researches, since only two 
patients presented an H/A z-score below -2, being then classified 
as bearers of chronic malnutrition with growth delay.
More research is needed with adolescents or children 
with autoimmune hepatitis regarding levels of  essential 
micronutrients, such as Zn, so as to evaluate the need for 
nutrient supplements for the patients. A good nutritional 
status and an adequate energy and nutrient intake act together 
with the medication to combat liver disease and avoid harm 
to the growth and development of children and adolescents. 
That is why it is very important to monitor periodically 
the nutritional status and the dietary intake of the patients 
throughout the ambulatory and hospital treatment.
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